Quality-of-Life Among Non-Prescription Medicine Consumers - Are They Different?

Published May 17, 2013
Penang, Malaysia - The study “Health-Related Quality of Life among Nonprescription Medicine Customers in Malaysia” was motivated by the significant increase of non-prescription medicines consumption that may have serious consequences on the individual and collective health of the population. In Malaysia, non-prescription medicines are mostly purchased by out-of-pocket money. As the non-prescription medicine consumers reflect self-medication practices, the measurement of their quality of life in this population is an important public health endeavor that could be used to inform health policy makers on the general health status of the population and impact on such practice on their quality of life. A nationwide cross-sectional survey that was conducted among 2729 pharmacy consumers in 59 randomly selected community pharmacies in Malaysia found that the mean EQ-5D and EQ-VAS score among non-prescription medicines consumers were significantly lower compared to average adult Malaysian population. Locality, age, ethnicity, household income per month, type of occupation and type of non-prescription medicine purchased were associated with differences in the health status of non-prescription medicine consumers. This study aims to determine the quality of life among community pharmacy’s consumers in Malaysia as measured by EuroQoL instrument. The quality of life among non-prescription medicine consumers were lower compared to general population because most individuals who engaged in the self-medication to seek relief from, amelioration of, or cure of symptom, or illness. Consumers who had lower quality of life were those who are older, lives in rural areas, have low income and education level, and purchased blood and blood forming medicines from community pharmacy. “The project looks great... a big undertaking and very important stuff. I admire the fact that you are aiming at the national level for this type of data!” Jeff Taylor, Professor of Pharmacy, College of Pharmacy and Nutrition, University of Saskatchewan, quoted. Dr Asrul Akmal Shafie, PhD, author of this study states: “This research clearly suggest that the quality of life among non-prescription medicines consumers were lower compared to general population. In addition, besides socio-demographic factors, the types of medicine purchased were also associated by their well being, hence, could be the focus of future research”.
Value in Health Regional Issues  (ISSN 2212-1099) is a scientific journal that encourages and enhances the science of pharmacoeconomic/health economic and health outcomes research and its use in health care decisions. The journal is published up to three times a year with one issue focusing on the Asia region, one issue focusing on the Latin America region, and one issue focusing on the Central & Eastern Europe, Western Asia and Africa regions. The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health.

Related Stories

Health Equity Research Goes Global—Without Waiting for Perfect Data

Feb 9, 2026

Value in Health Regional Issues announced the publication of a special collection of research papers in showing that meaningful progress in health equity research is occurring across regions and in settings with different data environments and policy needs.

Value in Health Regional Issues Expands Editorial Scope and Reveals Plans to Transition to Gold Open Access Model

Jan 23, 2024

Value in Health Regional Issues, an official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the expansion of its editorial scope and its plan to transition to a gold open access journal.

Empowering Change: Transforming Health Systems in Low- and Middle-Income Countries

Jan 22, 2024

ISPOR announced the publication of a special themed section of research papers in Value in Health Regional Issues that highlight innovative approaches to improving health outcomes in low- and middle-income countries through partnerships between health economics researchers and policy makers.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×